Antibody Drug Trials Licensing Regulation 
XTalks
APRIL 26, 2021
It is the world’s first and only licensed malaria vaccine and also the first licensed for use against a human parasitic disease of any kind. Children have been the focus of malaria vaccine and drug trials because over 90 percent of deaths attributable to malaria are in African children under the age of five.
Drug Discovery World
FEBRUARY 20, 2023
AstraZeneca’s Evusheld became the first antibody combination for pre-exposure prophylaxis (PrEP) against Covid-19 licensed in the UK. The approval was based on results from the PROpel Phase III trial, however, the drug was rejected by UK regulator NICE because it requires expensive genetic testing.
Expert insights. Personalized for you.
105 
Let's personalize your content